InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.92
(
0.10%
)
US TECH 100
19,138.40
(
-0.36%
)
Dow Jones
39,539.45
(
0.99%
)
Brent Oil
84.73
(
0.85%
)
Bitcoin
61,097.27
(
-3.27%
)
Post# of 252316
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: rkrw post# 104584

Monday, 09/20/2010 7:16:22 AM

Monday, September 20, 2010 7:16:22 AM

Post# of 252316

What's more interesting to me is what drugs will be combined with PLX to extend the impressive but still relatively modest duration.

And resistance (in addition to limited duration). GSK is running a combo trial of BRAF + MEK Inhibitors in melanoma to eliminate resistance.

http://clinicaltrials.gov/ct2/show/NCT01072175?term=GSK2118436++GSK1120212&rank=1
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up